Position in ERAS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,737,023
New position
Shares Held
354,575
first reported quarter
Ownership
0.114%
of shares outstanding
% of Portfolio
4.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026ACUTA CAPITAL PARTNERS, LLC holds $134,918,104 across 23 Biotechnology names. ERAS ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
84,901 | $27,354,253 | |
| 2 | TERN |
Terns Pharmaceuticals, Inc.
|
495,772 | $26,137,099 | |
| 3 | WHWK |
Whitehawk Therapeutics, Inc.
|
3,410,402 | $11,765,886 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
441,831 | $9,243,104 | |
| 5 | DRUG |
Bright Minds Biosciences Inc.
|
111,996 | $8,172,348 | |
| 6 | STRO |
Sutro Biopharma, Inc.
|
269,425 | $6,711,376 | |
| 7 | ERAS |
Erasca, Inc.
This page
|
354,575 | $5,737,023 | |
| 8 | SRZN |
Surrozen, Inc./DE
|
172,847 | $5,035,033 |
All Filings in ERAS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,737,023 | 354,575 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||